Deutsche Bank Reaffirms Buy Rating for Johnson Matthey (JMAT)

Johnson Matthey (LON:JMAT)‘s stock had its “buy” rating reiterated by investment analysts at Deutsche Bank in a research report issued on Thursday. They currently have a GBX 4,500 ($58.80) price objective on the stock. Deutsche Bank’s target price would indicate a potential upside of 47.16% from the stock’s previous close.

Other research analysts also recently issued reports about the stock. Liberum Capital restated a “buy” rating and issued a GBX 4,000 ($52.27) price target on shares of Johnson Matthey in a research report on Thursday, July 26th. Berenberg Bank restated a “buy” rating and issued a GBX 4,300 ($56.19) price target on shares of Johnson Matthey in a research report on Monday, September 17th. Credit Suisse Group restated an “outperform” rating on shares of Johnson Matthey in a research report on Thursday, August 23rd. Finally, UBS Group restated a “sell” rating on shares of Johnson Matthey in a research report on Thursday, October 25th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of GBX 3,827.78 ($50.02).

LON JMAT opened at GBX 3,058 ($39.96) on Thursday. Johnson Matthey has a 12 month low of GBX 2,681 ($35.03) and a 12 month high of GBX 3,511 ($45.88).

Johnson Matthey (LON:JMAT) last posted its quarterly earnings results on Wednesday, November 21st. The company reported GBX 109 ($1.42) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of GBX 108 ($1.41) by GBX 1 ($0.01).

In other news, insider John Walker acquired 12 shares of the business’s stock in a transaction that occurred on Wednesday, October 17th. The shares were purchased at an average cost of GBX 3,093 ($40.42) per share, for a total transaction of £371.16 ($484.99). Over the last quarter, insiders purchased 36 shares of company stock worth $116,928.

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Recommended Story: Do Tariffs Work?

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply